Yoichi Furukawa Selected Research

Yoichi Furukawa Research Topics

Disease

48	Neoplasms (Cancer) 03/2021 - 01/2002
22	Colorectal Neoplasms (Colorectal Cancer) 08/2022 - 03/2002
20	Carcinogenesis 01/2021 - 08/2002
12	Colonic Neoplasms (Colon Cancer) 04/2017 - 03/2002
10	Hepatocellular Carcinoma (Hepatoma) 08/2010 - 06/2002
7	Breast Neoplasms (Breast Cancer) 10/2019 - 02/2006
6	Stomach Neoplasms (Stomach Cancer) 01/2020 - 12/2002
4	Adenocarcinoma 03/2021 - 06/2002
4	Cholangiocarcinoma 03/2008 - 06/2005
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 03/2004
3	Carcinoma (Carcinomatosis) 09/2005 - 08/2002
2	Infections 01/2022 - 10/2006
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 12/2016 - 12/2012
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2015 - 02/2004
2	Neoplasm Metastasis (Metastasis) 02/2010 - 02/2004
2	Testicular Neoplasms (Testicular Cancer) 08/2005 - 08/2004
2	Adenoma (Adenomas) 02/2004 - 06/2002
1	Primary Myelofibrosis (Myelosclerosis) 01/2022
1	Microsatellite Instability 03/2021
1	Bacteremia 01/2021
1	HIV Infections (HIV Infection) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Dysbiosis 01/2021
1	Clostridium Infections 01/2021
1	Glucose Metabolism Disorders 01/2021
1	Inflammation (Inflammations) 01/2021
1	Disease Progression 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2020
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Neutropenia 01/2019

Drug/Important Bio-Agent (IBA)

30	Complementary DNA (cDNA)IBA 09/2010 - 01/2002
22	Proteins (Proteins, Gene)FDA Link 03/2021 - 06/2003
9	Small Interfering RNA (siRNA)IBA 01/2020 - 05/2004
8	Pharmaceutical PreparationsIBA 01/2021 - 01/2002
6	CateninsIBA 08/2022 - 01/2014
6	AntigensIBA 09/2010 - 08/2004
5	beta CateninIBA 12/2005 - 08/2002
4	Histones (Histone)IBA 01/2022 - 10/2005
4	Bevacizumab (Avastin)FDA Link 01/2021 - 10/2016
4	TCF Transcription FactorsIBA 03/2020 - 10/2002
4	Biological ProductsIBA 08/2014 - 11/2004
4	Peptides (Polypeptides)IBA 09/2010 - 12/2004
4	Tumor Biomarkers (Tumor Markers)IBA 06/2005 - 06/2003
3	Estrogen ReceptorsIBA 10/2019 - 10/2014
3	Aromatase InhibitorsIBA 10/2019 - 10/2014
3	MutL Protein Homolog 1IBA 08/2019 - 12/2012
3	HLA-A24 AntigenIBA 09/2010 - 10/2004
3	Histone MethyltransferasesIBA 11/2007 - 08/2004
3	HLA-A*02:01 antigenIBA 05/2006 - 12/2004
3	Calcibiotic Root Canal SealerIBA 11/2004 - 02/2004
3	OligonucleotidesIBA 01/2004 - 06/2002
2	Lysine (L-Lysine)FDA Link 01/2022 - 01/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 04/2003
2	CytokinesIBA 01/2021 - 08/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 02/2010
2	N- (3- phenyl- n- propyl)- 1- phenyl- 2- aminopropane (PPAP)IBA 01/2020 - 08/2019
2	InterferonsIBA 01/2019 - 11/2017
2	Gemcitabine FDA Link 01/2019 - 04/2003
2	LigandsIBA 11/2018 - 07/2009
2	Estrogens (Estrogen)FDA Link 12/2016 - 10/2014
2	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 12/2015
2	Docetaxel (Taxotere)FDA Link 10/2016 - 04/2003
2	Biomarkers (Surrogate Marker)IBA 08/2011 - 08/2010
2	MethyltransferasesIBA 01/2011 - 02/2006
2	GlypicansIBA 12/2004 - 06/2003
2	Neoplasm Antigens (Tumor Antigens)IBA 12/2004 - 10/2004
2	EpitopesIBA 12/2004 - 12/2004
1	ChromatinIBA 01/2022
1	Polycomb Repressive Complex 2IBA 01/2022
1	Surface-Active Agents (Surfactants)IBA 03/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	AutoantibodiesIBA 01/2021
1	immune RNA (I-RNA)IBA 01/2021
1	alpha-hydroxyglutarateIBA 01/2021
1	Toll-Like Receptor 7IBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	LuciferasesIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	TubulinIBA 12/2020
1	PTC596IBA 12/2020
1	Tubulin ModulatorsIBA 12/2020
1	PTC-028IBA 12/2020
1	Exosome Multienzyme Ribonuclease ComplexIBA 01/2020
1	hydrogen sulfite (bisulfite)IBA 08/2019
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 08/2019
1	5-Methylcytosine (5 Methylcytosine)IBA 08/2019
1	ErbB Receptors (EGF Receptor)IBA 12/2018
1	Selective Estrogen Receptor Modulators (SERM)IBA 12/2018

Therapy/Procedure

7	Immunotherapy 09/2010 - 08/2004
6	Therapeutics 03/2021 - 04/2016
6	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
6	Lasers (Laser) 06/2005 - 06/2002
1	Ligation 11/2021
1	Art Therapy 01/2021
1	Fecal Microbiota Transplantation 01/2021
1	Phage Therapy 01/2020